BlackRock Inc. - CANTEL MEDICAL CORP ownership

CANTEL MEDICAL CORP's ticker is CMD and the CUSIP is 138098108. A total of 232 filers reported holding CANTEL MEDICAL CORP in Q4 2020. The put-call ratio across all filers is 1.87 and the average weighting 0.3%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of CANTEL MEDICAL CORP
ValueSharesWeighting
Q1 2021$388,139,000
+1.7%
4,861,453
+0.5%
0.01%
-8.3%
Q4 2020$381,649,000
+92.7%
4,839,567
+7.4%
0.01%
+71.4%
Q3 2020$198,052,000
-2.9%
4,507,336
-2.2%
0.01%
-12.5%
Q2 2020$203,910,000
+64.0%
4,610,227
+33.1%
0.01%
+33.3%
Q1 2020$124,329,000
-50.1%
3,463,164
-1.5%
0.01%
-40.0%
Q4 2019$249,250,000
-2.7%
3,515,502
+2.7%
0.01%
-9.1%
Q3 2019$256,060,000
-8.7%
3,423,238
-1.6%
0.01%
-8.3%
Q2 2019$280,431,000
+22.3%
3,477,569
+1.5%
0.01%
+20.0%
Q1 2019$229,212,000
-14.8%
3,426,707
-5.1%
0.01%
-28.6%
Q4 2018$268,906,000
-20.1%
3,611,910
-1.2%
0.01%
-6.7%
Q3 2018$336,426,000
-2.2%
3,654,430
+4.4%
0.02%
-6.2%
Q2 2018$344,145,000
-26.3%
3,498,827
-16.5%
0.02%
-27.3%
Q1 2018$467,060,000
-4.5%
4,192,254
-11.8%
0.02%
-4.3%
Q4 2017$489,014,000
+8.0%
4,753,694
-1.2%
0.02%0.0%
Q3 2017$452,902,000
+20.4%
4,809,419
-0.4%
0.02%
+15.0%
Q2 2017$376,271,000
-8.9%
4,829,567
-6.4%
0.02%
-13.0%
Q1 2017$413,151,000
+31803.6%
5,157,923
+31272.3%
0.02%
+1050.0%
Q4 2016$1,295,000
+78.4%
16,441
+76.5%
0.00%
+100.0%
Q3 2016$726,000
+69.2%
9,314
+48.8%
0.00%0.0%
Q2 2016$429,000
+155.4%
6,259
+165.8%
0.00%
Q1 2016$168,000
+150.7%
2,355
+119.5%
0.00%
Q4 2015$67,000
+39.6%
1,073
+28.5%
0.00%
Q3 2015$48,000
-5.9%
835
-12.4%
0.00%
Q2 2015$51,000
+6.2%
953
-5.6%
0.00%
Q1 2015$48,000
+9.1%
1,0100.0%0.00%
Q4 2014$44,000
+25.7%
1,0100.0%0.00%
Q3 2014$35,000
-5.4%
1,0100.0%0.00%
Q2 2014$37,000
+32.1%
1,010
+21.8%
0.00%
Q1 2014$28,0000.0%8290.0%0.00%
Q4 2013$28,000
+7.7%
8290.0%0.00%
Q3 2013$26,000
-33.3%
829
-28.1%
0.00%
Q2 2013$39,0001,1530.00%
Other shareholders
CANTEL MEDICAL CORP shareholders Q4 2020
NameSharesValueWeighting ↓
IFP Advisors, Inc 0$00.00%
View complete list of CANTEL MEDICAL CORP shareholders